Filing Flows › Intuitive Surgical (ISRG) › R&D spending
Intuitive Surgical (ISRG) R&D spending by quarter
Intuitive Surgical's R&D spending was $408M in Q3 2026 (third quarter 2026), +10% from Q2 2026. Over the last 7 quarters it ranged from $313M (Q2 2025) to $408M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $408M | +10% | +24% |
| Q2 2026 | $371M | +2% | +18% |
| Q1 2026 | $362M | +3% | +14% |
| Q4 2025 | $353M | +7% | — |
| Q3 2025 | $329M | +5% | — |
| Q2 2025 | $313M | -0.9% | — |
| Q1 2025 | $316M | — | — |
Q3 2026 at a glance
Intuitive Surgical, Q3 2026: revenue $3.0B (+22% year over year), operating margin 19.4%, net earnings $523M, operating cash flow $1.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Intuitive Surgical's R&D spending?
Intuitive Surgical's R&D spending was $408M in Q3 2026 (third quarter 2026), +10% from Q2 2026.
How has Intuitive Surgical's R&D spending changed?
Over the last 7 quarters it ranged from $313M (Q2 2025) to $408M (Q3 2026).